Who owns Catalyst Biosciences?

Tip: Access positions for across all investors

Analyze quarterly positions in Catalyst Biosciences with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Catalyst Biosciences stock

Who bought or sold Catalyst Biosciences this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Advisory Services Network 66.00 $1.7k 100% Dec 2023
 View chart

Who sold out of Catalyst Biosciences?

Fund or Company Name Date Sold Shares Held Valued At
Vanguard Group Sep 2023 207k $100k
Kynam Capital Management Sep 2023 90k $43k
Nantahala Capital Management Sep 2023 68k $33k
Barclays Sep 2023 60k $29k
Parallax Volatility Advisers Sep 2023 57k $27k
Citadel Advisors Sep 2023 49k $24k
Colorado Capital Management Sep 2023 34k $16k
Hsbc Holdings Sep 2023 33k $16k
Bank of America Corporation Sep 2023 23k $11k
Two Sigma Securities Sep 2023 20k $9.7k
Raymond James & Associates Sep 2023 13k $6.2k
Arete Wealth Advisors Sep 2023 11k $5.2k
Jpmorgan Chase & Co Sep 2023 7.1k $3.5k
Cutler Sep 2023 5.5k $2.0k
UBS Group Sep 2023 5.1k $2.4k
Advisor Group Holdings Sep 2023 390.00 $188.019000
Bnp Paribas Arbitrage, Snc Sep 2023 277.00 $134.012600
Royal Bank of Canada Sep 2023 253.00 $0
Wells Fargo & Company Sep 2023 201.00 $97.002600